SEARCH

Blog

Recent Posts

Streck Launches Nucleic Acid Plus BCT™ to Reduce Pre-Analytical Variability Across Multi-Analyte Workflows 

La Vista, Nebraska – Streck is pleased to announce the launch of Nucleic Acid Plus BCT™, a blood collection tube designed to stabilize cell-free DNA (cfDNA), cell-free RNA (cfRNA), extracellular vesicles (EVs) and select plasma proteins from a single blood draw. Formerly known as Protein Plus BCT™, this product has expanded its intended use claims to include cfDNA and cfRNA alongside EVs and plasma proteins …

Streck receives IVD clearance of MDx-Chex controls for use with Diasorin LIAISON PLEX Blood Culture Assays 

La Vista, Nebraska – Streck is pleased to announce the U.S. Food and Drug Administration (FDA) clearance of three MDx-Chex® controls for sepsis testing as in vitro diagnostics (IVD). MDx-Chex for BCY, MDx-Chex for BCP and MDx-Chex for BCN are true patient-like, ready-to-use, full-process molecular quality controls designed for verification of the DiaSorin LIAISON PLEX® Yeast, Gram-Positive and Gram-Negative Blood Culture Assays, respectively.   Sepsis affects more than 1.7 million …

Streck’s CD-Chex™ Daily Delivers 51-Marker Coverage in a Single, Assayed Vial for Standardized Flow Cytometry QC

La Vista, Nebraska – Streck is pleased to announce the launch of CD-Chex™ Daily, the newest addition to the CD-Chex line of flow cytometry quality controls. CD-Chex Daily is a ready-to-use, assayed quality control designed to simplify and modernize daily QC workflows for flow cytometry laboratories. CD-Chex Daily provides comprehensive coverage across 51 markers in …